|
| |
|
Sify.com » Topics » Glenmark Pharma
Glenmark Pharma News
Glenmark close to final clinical trials for asthma, arthritis drugs Glenmark Pharmaceuticals is set to enter the final stage of clinical trials for its new drug, Revamilast, across several countries this year. It is meant for treatment of inflammatory disorders like asthma and rheumatoid arthritis. Glenmark may soon seek approval for Phase-III trials in the US, UK and India. “Glenmark plans to file an IND (Investigational New Drug application) for Revamilast
Sensex fails to hold early gains, ends 60 points down
Glenmark Pharma Q3 net nearly halves
Higher US drug sales pep up revenue show
Strong growth performance of generic drug sales in the US market helped Indian pharmaceutical companies record 17-19 per cent year-on-year growth in revenues for the September 2011 quarter.
Analysts' corner
TATA MOTORS Glenmark Pharma Galleries
|
|
|
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre. Site optimized for Internet Explorer 5.5 and above. See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise | |
